Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Dec 1;46(12):e577-e578.
doi: 10.1097/RLU.0000000000003803.

Cystic Hepatic Neuroendocrine Tumor: A Rare Entity

Fabian Haupt  1 , Ali Afshar-Oromieh  2 , Verena Carola Obmann  1 , Adrian Thomas Huber  1 , Martin Maurer  1
Affiliations
Case Reports

Cystic Hepatic Neuroendocrine Tumor: A Rare Entity

Fabian Haupt et al. Clin Nucl Med. .

Abstract

A 70-year-old man presented with unspecific abdominal symptoms and weight loss was referred for a sonographic examination. Sonography revealed 3 cystic hepatic masses in an otherwise unremarkable liver. Contrast-enhanced MRI of the liver was performed to characterize the hepatic lesions and elucidate their etiology. The differential diagnosis was primarily parasitic disease or metastases with cystic transformations. 68Ga-DOTATOC PET/CT revealed the neuroendocrine origin of these lesions, confirmed by biopsy. However, the primary site of the neuroendocrine tumor remained unclear, leaving primary hepatic neuroendocrine tumor and neuroendocrine cancer of unknown primary as possible diagnostic options.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest and sources of funding: none declared.

References

    1. Erickson LA, Papouchado B, Dimashkieh H, et al. Cdx2 as a marker for neuroendocrine tumors of unknown primary sites. Endocr Pathol . 2004;15:247–252.
    1. Perren A, Couvelard A, Scoazec JY, et al. ENETS consensus guidelines for the standards of care in neuroendocrine tumors: pathology: diagnosis and prognostic stratification. Neuroendocrinology . 2017;105:196–200.
    1. Jia C, Zhang Y, Xu J, et al. Experience in primary hepatic neuroendocrine tumor. Turk J Gastroenterol . 2012;23:546–551.
    1. Landen S, Elens M, Vrancken C, et al. Giant hepatic carcinoid: a rare tumor with a favorable prognosis. Case Rep Surg . 2014;2014:456509.
    1. Kehagias D, Moulopoulos L, Smirniotis V, et al. Imaging findings in primary carcinoid tumour of the liver with gastrin production. Br J Radiol . 1999;72:207–209.

Publication types

LinkOut - more resources